Article

Animal model vital in future treatment for AMD

Philadelphia, PA-University of Pennsylvania School of Medicine researchers have created the first animal model of age-related macular degeneration (AMD).

Philadelphia, PA-University of Pennsylvania School of Medicine researchers have created the first animal model of age-related macular degeneration (AMD).

"To better develop treatments for preventing the progression of AMD, we need to understand the real biochemical details of how AMD occurs," said lead author Eric A. Pierce, MD, PhD, associate professor of ophthalmology at Penn's K.M. Kirby Center for Molecular Ophthalmology. "To do that, we need a model, and now we have one."

"By making this particular mutant mouse, we've made a model of early macular degeneration that's caused by a mutation we know produces macular degeneration in people," said Pierce. "We think it's going to be a good model to study the pathogenesis of basal deposits."

One type of macular degeneration is thought to be caused by a mutation in the Efemp1 gene. Dr. Pierce and colleagues introduced the disease causing mutation into the Efemp1 gene of the mice.

They plan to use the mice to study how basal deposits form, what they are made of, and to test potential treatments to prevent basal deposit formations. The study is in the October issue of Human Molecular Genetics.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.